12076/TUB TRL 4
Antibiotics

This invention enables the production of albicidine, which could form the basis for novel, highly effective and bacteria-resistant antibiotics.

12009/TUB TRL 3
Artificial Tooth

In case of tooth loss, this invention enables the production of easily available, long-term stable and physiological grafts. The germ that induces later tooth growth is cultivated from human adult stem cells. -> ! This technology is not yet available for patients and will not be in the foreseeable future. ! <-

19024/TUB TRL 6
Innovative fluorescence probes for the detection of calcifications

The invention enable highly sensitive and selective fluorescent labelling of calcium deposits (e.g. hydroxyapatite) in tissue samples and allow the imaging detection of microcalcifications.

17011/TUB TRL 5
Oncolytic Coxsackievirus Variante PD for Treatment of Cancer

This invention enables the production of an oncolytic virus variante, enabling a novel specific treatment of malignant cancer. (in vivo PoC, TRL 5)

20052/TUB TRL 4
Propagation method for kefir grains’ microbial consortia

Some of the most important and abundant bacteria of the natural kefir microbial community in kefir grain-based beverages are very slow growing species and thus not used in industrial relevant starter cultures. This invention provides a method to use these species in a way that making the production of a synthetic kefir feasible for industrial scale production reassembling the organoleptic and health-benefiting characteristics of home-made kefirs more closely than current industrial kefirs.

14035/TUB TRL 4
Protein verification with Aptamers

This Innovation enables the easy marking and separating of different Proteins in a single sample.

17024/TUB TRL 4
Synthesis of Omphalotin A and familiar Secundary Metabolites

This Invention enables the Synthesis of Omphalotin A and modified secundary metabolites for the development of novel antibiotics.

14014/TUB TRL 4
Synthesis of Secondary Metabolites in Filamentous Fungi

This Invention contains the process of synthesis of secondary metabolites in fungal host organisms for the production of novel antibiotics.